Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Grupo Biotoscana gets Latin American rights to Basilea's Cresemba and Zevtera

Executive Summary

Basilea Pharmaceutica International Ltd. licensed Grupo Biotoscana SL exclusive rights to commercialize and distribute the antifungal Cresemba (isavuconazole) and antibiotic Zevtera (ceftobiprole) in 19 countries in Latin America including Brazil, Mexico, Argentina, and Colombia.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies